If you are asking whether elasty g plus is FDA-approved, the useful answer starts with a document check: FDA status must match the exact product, legal manufacturer, trade name or model, and intended use. A brand name on a product page, a seller statement, or a generic “FDA” badge is not enough.

Elasty G Plus is commonly presented online as a hyaluronic acid dermal filler rather than an electronic skincare device. In the United States, the FDA describes dermal fillers as medical device implants approved for specific facial or hand uses. That means the question is not simply “is the brand approved?” but “is this exact filler, from this exact manufacturer, approved for this exact indication in this market?”

FDA-approved, FDA-cleared, and FDA-registered mean different things

Beauty and injectable product listings often blur three separate regulatory ideas:

  • FDA-approved means FDA has approved the product through the relevant approval route. For dermal fillers, FDA points users to approved filler labeling and the PMA database.
  • FDA-cleared usually refers to a 510(k) decision for certain devices, where a manufacturer shows substantial equivalence to a legally marketed device. FDA explains 510(k) and PMA routes on its device approvals and clearances page.
  • FDA-registered or listed usually refers to an establishment or device listing record. FDA states that registration and listing do not denote approval, clearance, or authorization.

For that reason, a supplier saying “registered,” “FDA certificate,” “FDA facility,” or “compliant factory” does not prove that Elasty G Plus itself is FDA-approved.

How to check the claim in a practical way

  1. Confirm the product type. Decide whether the item is an injectable hyaluronic acid filler, thread, topical cosmetic, electronic device, or another product type. The FDA pathway depends on what the product is and what it claims to do.
  2. Record the legal manufacturer. Use the name printed on the carton, syringe label, instructions for use, or regulatory document. Do not rely only on an export seller or marketplace storefront.
  3. Record the exact trade name and presentation. Include “Elasty G Plus,” syringe volume, lidocaine status if shown, package size, lot number, and any model or product-line wording. Similar names do not automatically share the same authorization.
  4. Search the matching FDA resource. For dermal fillers, start from FDA’s FDA-approved dermal fillers page and PMA database. For other device types, use Devices@FDA, the 510(k) database, De Novo database, and product classification tools.
  5. Match the indication. FDA approval for one anatomical area or use does not automatically cover lips, nose, forehead, neck, body contouring, or another use. FDA separately lists unapproved filler uses that should not be assumed safe or authorized.
  6. Read the label or summary. A real FDA approval or clearance record should lead to product labeling, a summary, a decision letter, or a database entry that explains intended use and warnings.
  7. Ask the supplier for a traceable packet. Request country-specific authorization, approved labeling for the market where it will be used, lot number, expiry date, storage conditions, importer details, and any certificate of analysis or quality document that applies.

What to do if a seller only provides vague FDA wording

If the seller cannot provide a matching FDA approval, clearance, or authorization record for the exact product and use, treat “FDA-approved Elasty G Plus” as unverified marketing language. That does not decide whether the product has authorization in another country, and it does not prove a particular package is counterfeit. It only means the U.S. FDA claim has not been supported by the documents a buyer or clinic should be able to review.

For clinics, the strongest workflow is to keep a procurement file for each injectable: manufacturer, distributor, invoice, lot and expiry, storage record, regulatory authorization, and labeling. For patients, the safer question is direct: “Which FDA-approved dermal filler will you inject, for which indication, and can I read the patient labeling?” FDA also advises patients not to purchase dermal fillers online because such products could be counterfeit or not approved for use in the United States.

Safety checks are still needed when a filler is approved

FDA-approved dermal fillers still carry risks. FDA describes serious complications from unintended injection into blood vessels, including tissue death, vision abnormalities including blindness, stroke, and death. FDA recommends choosing a licensed health care provider trained in dermal filler injection and not self-injecting fillers. Approval status, product authenticity, correct indication, sterile handling, and injector training all matter together.

Short source list